Current Firm
Compound
Focus
AI, Biotech
Michael Dempsey approaches venture investing as applied science, spending most of his time reading scientific papers and building mental models of emerging fields before making investments rather than treating research as a side activity. He has developed formal processes to help deep-tech founders with long development cycles raise capital without compromising their technical missions to fit typical venture timelines, and regularly shares his detailed reasoning about value capture and market evolution through long-form public conversations.
Michael Dempsey is a Managing Partner, Compound at Compound, based in San Francisco, CA.
Michael's investment focus spans AI, Biotech, Web3, Robotics, Deeptech, primarily investing at the Seed, Series A stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Michael Dempsey is a Managing Partner, Compound at Compound, based in San Francisco, CA. Their investment focus includes AI, Biotech, Web3.
Michael Dempsey focuses on investments in AI, Biotech, Web3, Robotics, Deeptech through Compound. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Michael Dempsey is currently at Compound, headquartered in San Francisco, CA, serving as Managing Partner, Compound.